Published on 12 September 2024
Description:
The challenges of environmental sustainability; ‘Causes That Count, Health’ report; Rethinking neurodegeneration
Categories:
Pharmaceutical Market EuropePreview:
29 articles from this collection:
PME September 2024
PMEA 2024
Comment
PME Magazine
Contents
News - Sept 2024
Roche and Ascidian agree to $1.8bn neurological disease partnership
News - Sept 2024
Researchers identify new major cause of inflammatory bowel disease
Dermatology news - July/Aug 2024
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
DARWIN'S MEDICINE - Seeing giraffes in the boardroom
The evolutionary lessons for Bayer’s management restructure
MIKE DIXON - The partnership triangle
Collecting the right data in the right way for the right reasons
INNOVATIVE IMPACT BLOG - A social imperative: pharma’s essential role in online medical accuracy
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
GLOBAL PHARMA SURVEY - Results from Global Pharmaceutical Customer Experience survey
Across almost every sector, brands are multiplying their investment in creativity
RARE DISEASE THERAPY - Laying the groundwork for rare disease therapies
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
NEURODEGENERATION - Embracing risk: it’s time for big thinking in neurodegeneration
Picking your omnichannel direction requires a disciplined, scientific approach
DRUG SAFETY - Drug safety risk analysis – solving the puzzle of unstructured data
What value does your strategic planning add?
US INFLATION REDUCTION ACT - US government finalises first ten drug prices under Inflation
TL ICON - Innovation and flexibility in long-term follow-up studies
Ethical content sharing and the benefits of the CLA Pharmaceutical Licence
SUSTAINABILITY - The challenge of environmental management in the pharma industry
Iona Everson from PMGroup spoke to Doina Ionescu, managing director for the UK and Ireland at Merck, about her professional journey and experiences as a woman in the industry
TL HAVAS LYNX - Climate of Health: the prescription for survival
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
TL STRADOO - Digital biomarkers: reinventing patient monitoring and care
GLOBAL HEALTH - Causes That Count, Health’ report – key issues affecting global health
TL STRADOO - Digital biomarkers: reinventing patient monitoring and care
EXPERT STRATEGY - Strategy execution – ensuring it all fits together
HEALTHCARE COMMS - Inizio Engage merges Ashfield Event Experiences and WRG to create Emota
Inizio Engage has announced that it has merged Ashfield Event Experiences and WRG to create a new global experiential agency, Emota.
Appointments - July/August 2024
Appointments - September 2024
Appointments - September 2024
PharmaRole
PM SOCIETY
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services